Table 3.
Project | N | Before treatment | After treatment |
---|---|---|---|
DHI treatment group | 50 | ||
PON1 (μkat/L) | 100 ± 67 | 116 ± 73 | |
SOD (nU/ml) | 44.5 ± 4.3 | 56.4 ± 5.1*,# | |
MDA (nmol/ml) | 9.2 ± 1.4 | 5.5 ± 0.4*,# | |
Conventional therapy group | 48 | ||
PON1 (μkat/L) | 103 ± 67 | 109 ± 52 | |
SOD (nU/ml) | 43.8 ± 3.2 | 45.4 ± 3.9 | |
MDA (nmol/ml) | 9.1 ± 1.3 | 7.8 ± 0.5 |
P < 0.05, compared with before treatment;
P < 0.05, compared with conventional therapy.